At a glance
ClinicalIndex Comparison RecordN/AActive· 413 enrolled
Drug / intervention
OXINIUM DH Hip System +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-Center, Randomized Controlled Study of Efficacy and Safety of the OXINIUM◊ DH Total Hip Replacement System in Subjects With Non-Inflammatory Arthritis
In Brief
A clinical study evaluating OXINIUM DH Hip System and BIOLOX◊ for Hip Osteoarthritis. Active but no longer recruiting, targeting 413 participants.
Detailed Summary
The purpose of this study is to monitor safety of the participants implanted with the OXINIUM◊ DH Hip System up to 10-years post-implantation
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHip Osteoarthritis
Countries--
Collaborators--
Timeline
N/AActive
2015201620172018201920202021202220232024202520262027202820292030
Enrollment StartJan 2015
First PostedFeb 2015
Primary CompletionSep 2021
TodayJul 2026
Study CompletionFeb 2030
First PostedFeb 2, 2015
Enrollment StartJan 1, 2015
Primary CompletionSep 21, 2021
Study CompletionFeb 7, 2030
TodayJul 2, 2026
Enrollment to primary: 6.7 yearsPosted 11.4 years ago
Interventions
OXINIUM DH Hip Systemdevice
Investigational Group: OXINIUM DH Hip System
BIOLOX◊device
Control Group: BIOLOX◊ delta ceramic heads and XLPE liners